Jy-Ping Tsai

A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity

Chih‐Hsiang Leng, Shih‐Jen Liu, Jy-Ping Tsai et al. · Microbes and Infection · 2008 · 106 citations

Vaccination, Cross-protection, Vaccine Development +9

A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design

Hsin–Wei Chen, Shih‐Jen Liu, Hsueh‐Hung Liu et al. · Vaccine · 2009 · 68 citations

Vaccination, Engineering, Vaccine Development +12

A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates

Hsin–Wei Chen, Shih‐Jen Liu, Yi-Shiuan Li et al. · Archives of Virology · 2013 · 54 citations · Full text

Dengue Virus, Medicine, Viral Pathogenesis +9

Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice

Chen-Yi Chiang, Chien-Hsiung Pan, Mei‐Yu Chen et al. · Scientific Reports · 2016 · 39 citations · Full text

Lipidated Dengue-2 Envelope Protein Domain III Independently Stimulates Long-Lasting Neutralizing Antibodies and Reduces the Risk of Antibody-Dependent Enhancement

Chen-Yi Chiang, Chien-Hsiung Pan, Chun-Hsiang Hsieh et al. · PLoS neglected tropical diseases · 2013 · 35 citations · Full text